Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000351534

Medchemexpress LLC Zeteletinib | 2216753-97-6 | 98.3% | 500.47 | 100 MG
SDP

Supplier:  Medchemexpress LLC HY139590100MG

Encompass_Preferred

Zeteletinib is an orally active, selective RET kinase inhibitor with nanomolar potency against RET and over 300-fold selectivity against VEGFR2. It shows exquisite potency for the wild-type RET, RETV804M/L gatekeeper mutants, and the most common oncogenic RET mutation M918T. This compound exhibits potent antitumor activity and is intended for research use only.

  • Orally active and selective RET kinase inhibitor.
  • Nanomolar potency against RET.
  • Over 300-fold selectivity against VEGFR2.
  • Potent against wild-type RET, RETV804M/L gatekeeper mutants, and M918T oncogenic RET mutation.
  • Exhibits potent antitumor activity.

Catalog No. 50-003-51534


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.